|
MAP4K5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.421800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.442300E-03 |
| Normal-vs-Stage2 |
8.496400E-02 |
| Normal-vs-Stage3 |
9.661200E-01 |
| Normal-vs-Stage4 |
1.109010E-01 |
| Stage1-vs-Stage2 |
9.297800E-01 |
| Stage1-vs-Stage3 |
5.238200E-02 |
| Stage1-vs-Stage4 |
8.841200E-01 |
| Stage2-vs-Stage3 |
1.785840E-01 |
| Stage2-vs-Stage4 |
8.500200E-01 |
| Stage3-vs-Stage4 |
2.265000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.288400E-02 |
| Normal-vs-AfricanAmerican |
1.435970E-01 |
| Normal-vs-Asian |
6.014400E-01 |
| Caucasian-vs-AfricanAmerican |
7.526800E-01 |
| Caucasian-vs-Asian |
7.224200E-01 |
| AfricanAmerican-vs-Asian |
8.080000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.932000E-02 |
| Normal-vs-Female |
9.199200E-01 |
| Male-vs-Female |
1.422020E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.951600E-02 |
| Normal-vs-Extreme_Weight |
1.330190E-02 |
| Normal-vs-Obese |
6.020600E-01 |
| Normal-vs-Extreme_Obese |
7.180200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.773000E-01 |
| Normal_Weight-vs-Obese |
1.490590E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.473000E-01 |
| Extreme_Weight-vs-Obese |
3.598100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.601200E-01 |
| Obese-vs-Extreme_Obese |
3.098200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.831200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.443800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.018300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.536600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.506400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.306100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.317770E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.298350E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.394200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.026370E-01 |
| Normal-VS-Type2 PRCC |
8.758300E-04 |
| Normal-VS-KIRP CIMP |
2.267800E-01 |
| Normal-VS-Unclassified PRCC |
7.819400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.316290E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.840100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.414200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.887900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.680200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.129240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.039200E-04 |
| Normal-vs-N1 |
3.323400E-01 |
| Normal-vs-N2 |
5.817500E-02 |
| N0-vs-N1 |
3.980100E-03 |
| N0-vs-N2 |
7.407800E-01 |
| N1-vs-N2 |
1.433770E-01 |
|
|
